R&F Capital Advisors’s Core Laboratories CLB Stock Holding History

R&F Capital Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$240K	Buy	+2,078	New	+$242K	0.06%	483

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

R&F Capital Advisors's CLB Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in Core Laboratories (CLB) in Q1 2017: 2,078 shares worth $240K. The stake represents 0.06% of the portfolio and ranks #483 among its holdings.

360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

R&F Capital Advisors held 2,078 shares of Core Laboratories worth $240K as of Q1 2017.
Core Laboratories was a new R&F Capital Advisors position in Q1 2017.
Core Laboratories made up 0.06% of R&F Capital Advisors's portfolio in Q1 2017, its #483 holding.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.